Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population based study

Heidari, Ramin; Sadeghi, Masoumeh; Talaei, Mohammad; Rabiei, Katayoun; Mohammadifard, Noushin; Sarrafzadegan, Nizal

doi:10.1186/1758-5996-2-59

Cited by 53 publications

(63 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Heidari et al described the prevalence of MetS was 44.9%, 57.9% and 64.3% in premenopausal, perimenopausal and postmenopausal women respectively which was comparable to this results. 7 In a study by Figueiredo et al, the prevalence of MetS using IDF criteria was 64.5% which was comparable to this study. 8 However, the same criteria used by Pandey and colleagues documented the prevalence of 55% in Western India.…”

Section: Discussionsupporting

confidence: 75%

Association of metabolic syndrome and lower urinary tract symptoms amongst South Indian postmenopausal women

Kamaraj¹,

Londhe²,

Shetty³

et al. 2017

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: Women spend one third of their life in menopause. The age related anatomical and physiological changes predispose them to MetS and lower urinary tract symptoms (LUTS). The aim was to study the prevalence of metabolic syndrome (MetS) and lower urinary tract symptoms in postmenopausal women attending menopause clinic, to study the correlation of LUTS and body composition among women with MetS.Methods: 154 post-menopausal women who attended menopause clinic at the Christian Medical College Hospital Vellore, were recruited. MetS was diagnosed using IDF criteria. LUTS were assessed BFLUTS questionnaires. Blood was taken to assess serum fasting glucose and lipid proﬁle. DEXA was performed to assess the whole-body composition.Results: Of 154 postmenopausal women, 64% had MetS and 43% of women had a total LUTS score > 5. 90% of women had filling symptoms,57% had incontinence,17% had voiding symptoms,14 % had quality of life issues and 6 % had sexual symptoms. However, there was no statistical significant difference between two groups in correlating the variables of MetS with LUTS (P >0.05). The percentage of total body fat by DEXA scan was significantly greater (P=0.006) in women with MetS (37.32±5.04) when compared to the women without MetS (34.629±3.65).Conclusions: Prevalence of MetS among the study population was 64 %. LUTS were observed in 43% of the patients. There was no significant difference in LUTS in women with MetS and without Mets. However, there was a significant difference in body composition among women with and without MetS.

show abstract

Section: Discussionsupporting

confidence: 75%

Association of metabolic syndrome and lower urinary tract symptoms amongst South Indian postmenopausal women

Kamaraj¹,

Londhe²,

Shetty³

et al. 2017

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

show abstract

“…The prevalence of MS among postmenopausal women has been reported to (15), and 64.3% in Iran (16). MS is one factor that increases the mortality rate in both men and women (17).…”

Section: Discussionmentioning

confidence: 99%

Prevalence of metabolic syndrome in pre- and postmenopausal women

Marchi

Dell’Agnolo

Lopes

et al. 2017

Arch. Endocrinol. Metab.

View full text Add to dashboard Cite

Objective: The objective of this study was to determine the prevalence of metabolic syndrome (MS) and its components among pre-and postmenopausal women, as well as the association between menopausal status and MS. Materials and methods: A retrospective study was conducted at a reference cardiology outpatient clinic in a city located in Northwestern Paraná State, Brazil. A total of 958 medical records of symptomatic climacteric women evaluated between 2010 and 2014 were analyzed. The study consisted of two groups: pre-and post-menopausal women. MS was characterized according to the criteria of the National Cholesterol Education Program's Adult Treatment Panel III -NCEP-ATP III-2005. Results: MS was observed in 18.5% of the total study population; 9.4% of the premenopausal women and 22.2% of the postmenopausal women displayed MS, corresponding to a relative risk of 2.75. In addition, the frequency of MS increased with age. Regarding the components of MS, postmenopausal women were more likely to have high density lipoprotein (HDL-C) levels < 50 mg/dL; systolic blood pressure (SBP) values ≥ 130 mmHg or diastolic blood pressure (DBP) values ≥ 85 mmHg; and fasting glucose levels ≥ 100 mg/dL. Conclusion: MS was more prevalent among postmenopausal women than among premenopausal women. Arch Endocrinol Metab. 2017;61(2):160-6.

show abstract

“…3 Some other study reported that greater increased in waist-to-hip ratio and waist circumference, body mass index in postmenopausal women than that of premenopausal women. [10][11][12] Opposite nding was reported by some investigators who did not nd any signi cant di erence in BMI value in premenopausal and postmenopausal women. Some studies have been done on this regard in abroad but no published data has yet been available on this aspect in our country.…”

Section: Introductionmentioning

confidence: 76%